Abstract
By virtue of its tissue sparing properties and assessment of 100% of the margin of excised specimens, MMS is regarded as the gold-standard surgical treatment of high-risk non-melanoma skin cancers of the head and neck. From its original inception in the 1940s, modern day MMS has evolved to become a fresh tissue surgical technique, using frozen section margin control performed under local anaesthesia in an out-patient or day-case setting. In the UK, the increasing burden of skin cancer has resulted in a greater demand for MMS with over 32 units across the country providing the technique. This article is protected by copyright. All rights reserved.
| Original language | English |
|---|---|
| Pages (from-to) | 806-808 |
| Number of pages | 3 |
| Journal | British Journal of Dermatology |
| Volume | 176 |
| Issue number | 3 |
| Early online date | 5 Jul 2016 |
| DOIs | |
| Publication status | Published - 16 Mar 2017 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Safety, complications and patients' acceptance of Mohs micrographic surgery (MMS) under local anaesthesia - results from the UK MAPS (Mohs Acceptance and Patient Safety) Collaboration Group'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver